☰

Joanne W. Jang, Ph.D. - Publications

Affiliations: 
2006 University of Pennsylvania, Philadelphia, PA, United States 
Area:
Molecular Biology, Cell Biology, Oncology
Tree Info Similar researchers PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Jang JW, Parambi RJ, McBride SM, Goldsmith TA, Holman AS, Chan AW. Clinical factors predicting for prolonged enteral supplementation in patients with oropharyngeal cancer treated with chemoradiation. Oral Oncology. 49: 438-42. PMID 23357527 DOI: 10.1016/J.Oraloncology.2012.12.003  0.315
2013 Jang JW, Chan AW. Prevention and management of complications after radiotherapy for skull base tumors: a multidisciplinary approach. Advances in Oto-Rhino-Laryngology. 74: 163-73. PMID 23257562 DOI: 10.1159/000342293  0.399
2012 Jang J, Parambi R, Goldsmith T, Holman A, Wirth L, Clark J, Busse P, Chan A. Factors Associated With Prolonged Gastrostomy Tube Usage in Patients With Oropharyngeal Cancer Treated With Chemoradiation International Journal of Radiation Oncology*Biology*Physics. 84: S479. DOI: 10.1016/J.Ijrobp.2012.07.1270  0.311
2008 Jang JW. Anti-tumor mechanisms and regulation of survivin by selective cyclooxygenase-2 inhibitor The Korean Journal of Hepatology. 14: 305-308. PMID 18815453 DOI: 10.3350/kjhep.2008.14.3.305  0.332
2006 Jang JW, Boxer RB, Chodosh LA. Isoform-specific ras activation and oncogene dependence during MYC- and Wnt-induced mammary tumorigenesis. Molecular and Cellular Biology. 26: 8109-21. PMID 16908535 DOI: 10.1128/Mcb.00404-06  0.719
2005 Boxer RB, Jang JW, Sintasath L. Persistence of cancer after oncogene targeting Cancer Biology and Therapy. 4.  0.647
2004 Boxer RB, Jang JW, Sintasath L, Chodosh LA. Lack of sustained regression of c-MYC-induced mammary adenocarcinomas following brief or prolonged MYC inactivation. Cancer Cell. 6: 577-86. PMID 15607962 DOI: 10.1016/J.Ccr.2004.10.013  0.725
2003 Chodosh L, Boxer R, Moody S, Keister B, Sarkisian C, Jang J, Belka G, Blakely C, Portocarero C, Sterner C, Notarfrancesco K, Kauh E. Reversibility and progression in conditional transgenic mouse models of breast cancer Breast Cancer Research. 5: 5-5. DOI: 10.1186/Bcr664  0.493
Show low-probability matches.